To test this, we quantified the number of circulating tumor cells (CTCs) in mice that developed primary mammary tumors following injection of 4T1-537 parental, p66-CR (VC), p66-CR (WT), and p66-CR (S36A) breast cancer cells. Here, SHC1 is linked to neoplasm.